Fri Aug 4 16:36:36 2006
Complete replication of hepatitis C virus in cell culture
Lindenbach BD, Evans MJ, Syder AJ, et al.
SCIENCE 309 (5734): 623-626 JUL 22 2005
and the citing papers
stopwords, and 2-character and smaller words are excluded, Word count: 639, All words count: 954
Grand TLCS: 116, Grand TGCS: 195View: Overview | Sorted by word. |
Page 2 of 2: [ 1 2 ]
# | Word | Pubs | TLCS | TGCS
|
---|
201 | NON-STRUCTURAL | 1 | 0 | 0
|
202 | NONSTRUCTURAL | 1 | 0 | 0
|
203 | NOVEL | 4 | 1 | 1
|
204 | NS34A | 1 | 0 | 0
|
205 | NS5B | 1 | 0 | 0
|
206 | NS5B-NUCLEOLIN | 1 | 0 | 0
|
207 | NUMBER | 1 | 0 | 0
|
208 | OCCURS | 1 | 1 | 2
|
209 | OLIGONUCLEOTIDE-BASED | 1 | 0 | 0
|
210 | OPIATE | 1 | 0 | 0
|
211 | OPTIONS | 1 | 0 | 0
|
212 | OXIDIZED | 1 | 1 | 1
|
213 | OXLDL | 1 | 0 | 0
|
214 | PARALLEL | 1 | 0 | 0
|
215 | PARTICLE | 1 | 0 | 0
|
216 | PARTICLES | 4 | 0 | 0
|
217 | PATHOGENETIC | 1 | 1 | 2
|
218 | PATHWAY | 1 | 6 | 41
|
219 | PEPTIDASE | 1 | 0 | 0
|
220 | PEPTIDE | 2 | 0 | 0
|
221 | PESTIVIRUS | 1 | 1 | 1
|
222 | PH-DEPENDENT | 1 | 3 | 3
|
223 | PHANTOM | 1 | 0 | 0
|
224 | POLYMERASE | 2 | 1 | 1
|
225 | POLYPROTEIN | 1 | 0 | 0
|
226 | POTENT | 2 | 0 | 0
|
227 | POTENTIAL | 3 | 0 | 0
|
228 | PRACTICE | 1 | 0 | 1
|
229 | PREVENTION | 1 | 0 | 0
|
230 | PRIMARY | 1 | 0 | 0
|
# | Word | Pubs | TLCS | TGCS
|
---|
231 | PRODUCED | 1 | 0 | 0
|
232 | PRODUCTION | 3 | 4 | 5
|
233 | PROFILES | 1 | 0 | 0
|
234 | PROMOTE | 1 | 0 | 0
|
235 | PROPERTIES | 1 | 0 | 0
|
236 | PROSPECTS | 1 | 1 | 6
|
237 | PROTEASE | 3 | 0 | 0
|
238 | PROTEASE-DEPENDENT | 1 | 0 | 0
|
239 | PROTEIN | 5 | 6 | 42
|
240 | PROTEINS | 3 | 1 | 1
|
241 | PSEUDOPARTICLE | 1 | 0 | 0
|
242 | PSEUDOPARTICLES | 1 | 1 | 2
|
243 | QUANTITATIVE | 2 | 1 | 4
|
244 | RAT | 1 | 0 | 0
|
245 | REARRANGEMENT | 1 | 0 | 0
|
246 | RECENT | 1 | 0 | 1
|
247 | RECEPTOR | 2 | 0 | 0
|
248 | RECEPTORS | 2 | 0 | 0
|
249 | RECOMBINANT | 2 | 1 | 2
|
250 | RECULTURED | 1 | 2 | 2
|
251 | REGIONS | 1 | 0 | 0
|
252 | REPLICATES | 1 | 1 | 1
|
253 | REPLICATION | 12 | 83 | 95
|
254 | REPLICON | 4 | 1 | 1
|
255 | REPLICONS | 1 | 0 | 0
|
256 | REPORTER | 2 | 0 | 0
|
257 | REQUIRED | 1 | 0 | 0
|
258 | REQUIRES | 1 | 1 | 2
|
259 | RESEARCH | 1 | 0 | 0
|
260 | RESPONSES | 2 | 0 | 0
|
# | Word | Pubs | TLCS | TGCS
|
---|
261 | REVEALED | 1 | 1 | 1
|
262 | RIBAVIRIN | 4 | 4 | 18
|
263 | RIG-I | 1 | 6 | 41
|
264 | RNA | 9 | 1 | 2
|
265 | RNA-DEPENDENT | 1 | 1 | 1
|
266 | ROBUST | 1 | 2 | 2
|
267 | ROLE | 1 | 0 | 0
|
268 | SALIENT | 1 | 1 | 1
|
269 | SAR | 1 | 0 | 0
|
270 | SCAVENGER | 2 | 0 | 0
|
271 | SCH | 2 | 0 | 0
|
272 | SECRETION | 1 | 0 | 0
|
273 | SELECTIVE | 1 | 1 | 1
|
274 | SENSITIVE | 1 | 1 | 1
|
275 | SERINE | 1 | 0 | 0
|
276 | SHORT | 1 | 0 | 0
|
277 | SIGNAL | 2 | 0 | 0
|
278 | SIGNALING | 1 | 0 | 0
|
279 | SIGNALS | 1 | 0 | 0
|
280 | SIMULTANEOUS | 1 | 0 | 0
|
281 | SINUSOIDAL | 1 | 0 | 0
|
282 | SR-BI | 1 | 0 | 0
|
283 | STABLY | 1 | 2 | 2
|
284 | STAGES | 1 | 0 | 0
|
285 | STATINS | 1 | 0 | 0
|
286 | STEPS | 1 | 0 | 0
|
287 | STIMULATING | 1 | 0 | 0
|
288 | STRAIN | 2 | 1 | 1
|
289 | STRATEGIES | 1 | 0 | 0
|
290 | STRUCTURAL | 1 | 1 | 1
|
# | Word | Pubs | TLCS | TGCS
|
---|
291 | STRUCTURE | 1 | 0 | 0
|
292 | SUBCELLULAR | 1 | 1 | 1
|
293 | SUBGENOMIC | 2 | 0 | 0
|
294 | SUPPRESSES | 1 | 0 | 0
|
295 | SYNTHESIS | 1 | 0 | 0
|
296 | SYSTEM | 2 | 2 | 2
|
297 | TARGET | 1 | 0 | 0
|
298 | TARGETED | 1 | 6 | 41
|
299 | TARGETING | 1 | 0 | 0
|
300 | TARGETS | 2 | 1 | 1
|
301 | TEMPERATURE-DEPENDENT | 1 | 4 | 4
|
302 | TETRASPANIN | 1 | 0 | 0
|
303 | THERAPEUTIC | 3 | 0 | 0
|
304 | THERAPIES | 1 | 0 | 0
|
305 | THERAPY | 4 | 0 | 0
|
306 | THIENYL | 1 | 0 | 0
|
307 | THREE-DIMENSIONAL | 1 | 0 | 0
|
308 | TIME-AND | 1 | 4 | 4
|
309 | TISSUE | 1 | 1 | 2
|
310 | TOLL-LIKE | 1 | 0 | 0
|
311 | TRACT | 1 | 0 | 0
|
312 | TRANSLATION | 1 | 0 | 1
|
313 | TREATMENT | 1 | 3 | 15
|
314 | TRIGGER | 1 | 0 | 0
|
315 | TROJAN | 1 | 0 | 0
|
316 | TWO | 1 | 0 | 0
|
317 | TWO-AND | 1 | 0 | 0
|
318 | UNRAVELLING | 1 | 7 | 15
|
319 | UNSCRAMBLING | 1 | 3 | 9
|
320 | UPTAKE | 1 | 0 | 0
|
# | Word | Pubs | TLCS | TGCS
|
---|
321 | USING | 2 | 0 | 0
|
322 | VACCINE | 1 | 1 | 6
|
323 | VECTORS | 1 | 0 | 0
|
324 | VIABLE | 1 | 0 | 0
|
325 | VIRAL | 5 | 1 | 1
|
326 | VIROLOGIC | 1 | 0 | 1
|
327 | VIROLOGY | 1 | 0 | 0
|
328 | VIRUS | 47 | 108 | 165
|
329 | VIRUS-ASSOCIATED | 1 | 1 | 2
|
330 | VIRUS-HOST | 1 | 3 | 9
|
331 | VIRUS-INFECTED | 1 | 0 | 0
|
332 | VIRUS-LIKE | 2 | 0 | 0
|
333 | VIRUS-NEUTRALIZING | 1 | 0 | 0
|
334 | VIRUSES | 2 | 0 | 0
|
335 | VITRO | 2 | 2 | 2
|
336 | VIVO | 3 | 2 | 4
|
Page 2 of 2: [ 1 2 ]